Study to Evaluate the Safety and Immunogenicity of Nimenrix (Registered) in Healthy Infants, Given at 3 and 12 Months of Age
Clinical trial NCT04819113 · COMPLETED
Trial details
- NCT number
- NCT04819113
- Sponsor
- Pfizer
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2021-04-09
- Primary completion
- 2022-09-09
- Enrollment
- 149
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.